Pro- and Anti- Effects of Immunoglobulin A- Producing B Cell in Tumors and Its Triggers.

Ke Nan, Changhong Miao, Ziwen Zhong, Meilin Weng, Ying Yue, Wenchang Zhou, Zhiqiang Wang, Yiwei Chu, Ronghua Liu

Journal: Frontiers in immunology 2022;12():765044

PMID: 34868013

Abstract

["B cells are well known as key mediators of humoral immune responses the production of antibodies. Immunoglobulin A (IgA) is the most abundantly produced antibody isotype and provides the first line of immune protection at mucosal surfaces. However, IgA has long been a divisive molecule with respect to tumor progression. IgA exerts anti- or pro-tumor effect in different tumor types. In this review, we summarize emerging evidence regarding the production and effects of IgA and IgA cells in the tumor microenvironment (TME). Moreover, we discuss that the TME cytokines, host diet, microbiome, and metabolites play a pivotal role in controlling the class-switch recombination (CSR) of IgA. The analysis of intratumoral Ig repertoires and determination of metabolites that influence CSR may help establish novel therapeutic targets for the treatment of cancers.",{"copyright":"Copyright \u00a9 2021 Zhong, Nan, Weng, Yue, Zhou, Wang, Chu, Liu and Miao."}]
Address: Department of Anesthesiology, Zhongshan Hospital, Fudan University, Shanghai, China.; Department of Anesthesiology, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.; Department of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, China.; Shanghai Fifth People's Hospital and Key Laboratory of Medical Epigenetics and Metabolism, Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.